https://www.selleckchem.com/products/fm19g11.html
Coronavirus disease 2019 (COVID-19) is an acute respiratory illness with a high rate of hospitalization and mortality. Biomarkers are urgently needed for patient risk stratification. Red blood cell distribution width (RDW), a component of complete blood counts that reflects cellular volume variation, has been shown to be associated with elevated risk for morbidity and mortality in a wide range of diseases. To investigate whether an association between mortality risk and elevated RDW at hospital admission and during hospitalization exist
Like
Comment
Share
